| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.036 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |